M64HCl, a focal adhesion kinase activator, promotes intestinal mucosal healing in rats
Open Access
- 8 May 2025
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-11
Abstract
Intestinal mucosal injury may arise from various factors. While many drugs target the causative factors, none directly stimulate mucosal wound healing. We found that the specific focal adhesion kinase (FAK) activator, M64HCl, promotes intestinal mucosal healing in mice. This study aims to further validate the therapeutic impact of M64HCl on intestinal mucosal repair in rats as a second species. Wistar rats were assigned to one of four groups: normal control, 1-day injury + vehicle, 4-day injury + vehicle, or 4-day injury + M64HCl. Intestinal injury was induced by serosally applying 75% acetic acid. Immediately after injury, rats received either a continuous infusion of M64HCl (25 mg/kg/day) or its vehicle (saline). Four days post-injury, blood was drawn to measure M64HCl levels and assess liver and kidney function. The intestines were removed and opened, ulcer areas were photographed for size quantification, and tissues were fixed for histological and immunohistochemical analysis. M64HCl substantially reduced ulcer area on gross examination, while histological analysis showed alleviation of pathological changes with M64HCl treatment. Immunohistochemical analysis confirmed increased immunoreactivity for phosphorylated FAK in the epithelium adjacent to the injury in M64HCl-treated rats. However, there was no change in the percentage of Ki67-positive cells in each crypt at the edge of the ulcer area. Serum creatinine, ALT, and AST levels did not differ between the 4-day injury groups with or without M64HCl treatment. M64HCl, a water-soluble FAK activator, promotes acetic acid-induced ulcer healing in rats and may be useful in treating gastrointestinal mucosal injury.Keywords
Funding Information
- National Institutes of Health’s National Center for Advancing Translational Sciences (UL1TR002494)
- National Institutes of Health (U01HL152410)
This publication has 47 references indexed in Scilit:
- The intestinal epithelial-macrophage-crypt stem cell axis plays a crucial role in regulating and maintaining intestinal homeostasisLife Sciences, 2024
- A novel drug-like water-soluble small molecule Focal Adhesion Kinase (FAK) activator promotes intestinal mucosal healingCurrent Research in Pharmacology and Drug Discovery, 2022
- ZINC40099027 promotes monolayer circular defect closure by a novel pathway involving cytosolic activation of focal adhesion kinase and downstream paxillin and ERK1/2Cell and tissue research, 2022
- Feeling Things Out: Bidirectional Signaling of the Cell–ECM Interface, Implications in the Mechanobiology of Cell Spreading, Migration, Proliferation, and DifferentiationAdvanced Healthcare Materials, 2020
- Focal adhesion kinase signaling in unexpected placesCurrent Opinion in Cell Biology, 2017
- Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinaseJournal of Surgical Research, 2014
- Focal adhesion kinase and its signaling pathways in cell migration and angiogenesisAdvanced Drug Delivery Reviews, 2011
- Supraphysiologic extracellular pressure inhibits intestinal epithelial wound healing independently of luminal nutrient flowThe American Journal of Surgery, 2008
- RNA interference reveals a differential role of FAK and Pyk2 in cell migration, leading edge formation and increase in focal adhesions induced by LPA in intestinal epithelial cellsJournal of Cellular Physiology, 2006
- Human Caco-2 Intestinal Epithelial Motility Is Associated with Tyrosine Kinase and Cytoskeletal Focal Adhesion Kinase SignalsJournal of Surgical Research, 1998